Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry – ANNALS OF THE RHEUMATIC DISEASES

Hernández-Cruz, B; Otero-Varela, L; Freire-González, M; Busquets-Pérez, N; González, AJG; Moreno-Ramos, M; Blanco-Madrigal, JM; Manrique-Arija, S; Perez-Pampin, E; Ruiz-Montesino, D; Sánchez-Alonso, F; Sanchez-Piedra, C; Castrejón, I – 2024 –...

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs – BIOMEDICINE & PHARMACOTHERAPY

Muñoz-Barrera, L; Perez-Sanchez, C; Ortega-Castro, R; Corrales, S; Luque-Tevar, M; Cerdó, T; Sanchez-Pareja, I; Font, P; Lopez-Mejías, R; Calvo, J; Abalos-Aguilera, MC; Ruiz-Vilchez, D; Segui, P; Merlo, C; Perez-Venegas, J; Montesino, MDR; Rodriguez-Escalera, C;...